Supported

What the evidence supports

  • Hot flashes and night sweats: Systemic hormone therapy is a standard, well-studied option for these common vasomotor symptoms in appropriate candidates. Most of that research was done with FDA-approved hormone products.
  • Bone health: Estrogen plays a role in maintaining bone density, and bone loss can speed up during the menopause transition. Whether hormone therapy is appropriate for bone protection depends on the person's circumstances and other available options.
  • Vaginal and urinary symptoms: Vaginal estrogen and other appropriate treatments can help symptoms associated with genitourinary changes during menopause. Local treatment may be sufficient when symptoms are limited to this area.
Less clear

What depends on you

  • Sleep disruption related to menopause: HRT may help when sleep is being disrupted by hot flashes and night sweats.
  • Brain health: Brain health matters, but HRT should not be started solely to prevent memory loss or dementia.
  • Compounded hormones: Most of this evidence comes from FDA-approved hormone products. Evidence on the comparative safety and effectiveness of compounded preparations is limited, and potency can vary.
Our position

What we tell people

  • At Jellyphysh, we believe hormone care should begin with informed conversations—not blanket promises.
  • We want to make the science easier to understand, help you ask better questions, and support treatment decisions guided by qualified healthcare professionals.
  • No one-size-fits-all answers. No promises of overnight transformation. Just clear information and thoughtful care.
FDA update

What changed about HRT warnings?

  • In February 2026, the FDA announced that it had approved labeling changes for six menopausal hormone therapy products, removing certain statements about cardiovascular disease, breast cancer, and probable dementia from their boxed warnings. The changes were intended to clarify benefit-risk information.
  • It does mean the labeling of certain products has changed.
  • It does not mean every hormone formulation has identical risks.
  • It does not mean the risks of breast cancer, blood clots, stroke, or other adverse effects are irrelevant.
  • It does not mean everyone should start HRT.
  • The decision still needs to consider the person's age, time since menopause, medical history, symptoms, formulation, dose, and route of administration.
The terms

What about bioidentical and compounded hormones?

  • Bioidentical means that a hormone is chemically identical to a hormone produced by the human body. It does not automatically mean a product is compounded, natural, safer, or more effective.
  • There are FDA-approved bioidentical hormone products, including certain estradiol and progesterone medications.
  • Compounded hormone preparations are custom-made and are not FDA-approved in the same way as commercially approved medications. Compounded products may have a role in specific circumstances, but evidence on their comparative safety and effectiveness is limited, and potency can vary.
Testing

Do hormone levels need to be tested?

  • Not necessarily in every case.
  • For typical menopause symptoms, treatment decisions are often based on symptoms, age, menstrual history, medical history, and clinical assessment. Hormone levels can fluctuate substantially during perimenopause, so a single result may not explain what someone is experiencing.
  • Testing may still be appropriate in specific clinical circumstances. The decision should come from the treating clinician.

May be unsuitable or need specialist assessment

  • A history of breast or other estrogen-sensitive cancer.
  • Unexplained vaginal bleeding.
  • A history of blood clots, stroke, or certain cardiovascular conditions.
  • Active or significant liver disease.
  • Known or suspected pregnancy, where relevant.

Also good to know

  • Still having regular periods. Our online intake refers you to your own doctor first.
  • Being under 18.
  • Smoking, high blood pressure, migraines, or high cholesterol. Your provider will weigh these before prescribing.

These are examples, not a complete list. The risks differ between systemic and local vaginal treatments, and individual circumstances matter. Not sure whether something applies to you? Start the consultation anyway. A licensed provider reviews every answer.

Urgent

Stop and get help right away

Pain, swelling, or warmth in one leg, or sudden shortness of breath
Possible blood clot. Call 911.
Sudden severe headache, weakness on one side, trouble speaking, or vision changes
Possible stroke. Call 911.
Chest pain
Needs immediate evaluation.
A new breast lump, or yellowing of the skin or eyes
Get it checked promptly.
Common

Expected, no action needed unless it lasts

Breast tenderness
Common in the first few weeks
Usually eases as your body adjusts.
Bloating or mild fluid retention
Common early on
Usually settles.
Spotting or light bleeding
Common in the first months if you have a uterus
Mention it if it's heavy or doesn't settle.
Mild headache
Early weeks
Mention it if it lasts.
Skin irritation where you apply cream
Topical forms
Rotate where you apply it.
Nausea
Tablets, early on
Taking it with food may help.
Mention it

Tell your provider at your next check-in

Bleeding that starts again after it settled, or is heavy
Needs to be checked.
New or worse headaches or migraines
Your provider may change the dose or form.
Mood changes that worry you
Worth a conversation.
Breast tenderness that doesn't ease
A dose change may help.
No improvement after about 3 months
Worth a conversation about dose or form.
Weeks 1 to 4

Getting started

Some people notice hot flashes easing within the first few weeks. Breast tenderness or spotting is most likely now.

Weeks 4 to 12

Settling in

Much of the benefit for hot flashes and night sweats usually shows by 8 to 12 weeks. Vaginal symptoms can take 2 to 3 months.

Month 3

Review

Your first 3-month supply ends here, a natural point to review dose and form with your provider.

Ongoing

Keep checking

Your treatment should be reviewed at least once a year, including whether you still need it.

Monitoring

Hormone levels don't need to be tested in every case. For typical menopause symptoms, treatment decisions are often based on symptoms, age, menstrual history, medical history, and clinical assessment. Your provider decides whether testing is needed. Keep up your regular mammograms and annual check-ups with your primary care provider.

$289
and up for a 3-month supply (includes provider review, medication and shipping). Cash-pay, no insurance claims.
$0
charged if a provider doesn't prescribe. The hold is released.
48 hrs
Cancel at least 48 hours before your next billing date. Any charge after a successful cancellation is refunded.